Histopathology of Leishmania major infection: Revisiting L. major histopathology in the ear dermis infection model

Memorias do Instituto Oswaldo Cruz

Volumn 104, Issue 6, 2009, Pages 918-922

  Cangussú, Silvia Dantas ^a,b   de Souza, Carolina Carvalho ^a   Campos, Camila França ^a   Vieira, Leda Quercia ^a   Afonso, Luís Carlos Crocco ^b   Arantes, Rosa Maria Esteves ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

Author keywords

Infectious skin diseases; Leishmania major; Pathology

Indexed keywords

LEISHMANIA MAJOR;

EID: 70350287842     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762009000600017     Document Type: Article

References (17)

1. Baldwin T, Sakthianandeswaren A, Curtis JM, Kumar B, Smyth GK, Foote SJ, Handman E 2007. Wound healing response is a major contributor to the severity of cutaneous leishmaniasis in the ear model of infection. Parasite Immunol 29: 501-513.
2. Beil WJ, Meinardus-Hager G, Neugebauer DC, Sorg C 1992. Differences in the onset of the inflammatory response to cutaneous leishmaniasis in resistant and susceptible mice. J Leukoc Biol 52: 135-142.
3. Belkaid Y, Mendez S, Lira R, Kadambi N, Milon G, Sacks D 2000. A natural model of Leishmania major infection reveals a prolonged "silent" phase of parasite amplification in the skin before the onset of lesion formation and immunity. J Immunol 165: 969-977.
4. Chakour R, Guler R, Bugnon M, Allenbanch C, Garcia I, Mauël J, Louis J, Tacchini-Cottier F 2003. Both the Fas ligand and inductor alpha-deficient mice in chronic leishmaniasis reveal a protecible nitric oxide synthase are needed for control of parasite reptive replication within lesions in mice infected with Leishmania major whereas the contribution of tumor necrosis factor is minimal. Infect Immun 71: 5287-5295.
5. Diefenbach A, Schindler H, Donhauser N, Lorenz E, Laskay T, MacMicking J, Rollinghoff M, Gresser I, Bogdan C 1998. Type 1 interferon (IFNalpha/beta) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. Immunity 8: 77-87.
6. Gaafar A, el Kadaro AY, Theander TG, Permin H, Ismail A, Kharazmi A, el Hassan AM 1995. The pathology of cutaneous leishmaniasis due to Leishmania major in Sudan. Am J Trop Med Hyg 52: 438-442.
7. Heinzel FP, Sadick MD, Holaday BJ, Coffman RL, Locksley RM 1989. Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J Exp Med 169: 59-72.
8. Kopf M, Brombacher F, Kohler G, Kienzle G, Widmann KH, Lefrang K, Humborg C, Ledermann B, Solbach W 1996. IL-4-deficient Balb/c mice resist infection with Leishmania major. J Exp Med 184: 1127-1136.
9. Kropf P, Herath S, Weber V, Modolell M, Muller I 2003. Factors influencing Leishmania major infection in IL-4-deficient BALB/c mice. Parasite Immunol 25: 439-447.
10. Mohrs M, Ledermann B, Kohler G, Dorfmuller A, Gessner A, Brombacher F 1999. Differences between IL-4- and IL-4 receptor alpha-deficient mice in chronic leishmaniasis reveal a protective role for IL-13 receptor signaling. J Immunol 162: 7302-7308
11. Noben-Trauth N, Kropf P, Muller I 1996. Susceptibility to Leish-mania major infection in interleukin-4-deficient mice. Science 271: 967-990.
12. Pós Z, Müller K, Novák I, Buzás E, Solbach W, Falus A, Laskay T 2004. Different patterns of the L-histidine decarboxylase (hdc) gene expression in mice resistant and susceptible to experimental cutaneous leishmaniasis. Inflamm Res 53: 38-43.
13. Qadoumi M, Becker I, Donhauser N, Rollinghoff M, Bogdan C 2002. Expression of inducible nitric oxide synthase in skin lesions of patients with American cutaneous leishmaniasis. Infect Immun 70: 4638-4642.
14. Romão PRT, Santiago HC, Ramos CDL, De Oliveira CFE, Monteiro MC, Cunha FQ, Vieira LQ 2009. Mast cell degranulation contributes to susceptibility to Leishmania major. Parasite Immunol 31: 140-146.
15. Stenger S, Donhauser N, Thuring H, Rollinghoff M, Bogdan C 1996. Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase. J Exp Med 183: 1501-1514.
16. Tafuri WL, Santos RL, Arantes RM, Gonçalves R, de Melo MN, Michalick MS, Tafuri WL 2004. An alternative immunohistochemical method for detecting Leishmania amastigotes in paraffin-embedded canine tissues. J Immunol Methods 292: 17-23.
17. Wershil BK, Theodos CM, Galli SJ, Titus RG 1994. Mast cells augment lesion size and persistence during experimental Leishmania major infection in the mouse. J Immunol 152: 4563-4571.